BestAgeing - Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population / Edukad projektid

coordinating country [ DE ] search term [ UNIVERSITA CATTOLICA DEL SACRO CUORE ]

Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population

acronym:	BestAgeing
start:	2013-02-01
end:	2017-01-31

programme:	FP7 - Euroopa Liidu 7. raamprogramm
sub-programme:	HEALTH - Tervis
instrument:	CP-IP - Suuremahulised integreeritud projektid
call identifier:	FP7-HEALTH-2012-INNOVATION-1
project number:	306031
duration in months:	36
partner count:	19

abstract:	The ageing of the European population represents a rapidly rising social and economic challenge. Especially cardiovascular morbidity increases with age, but unfortunately, elderly patients are often difficult to diagnose due to confounding factors, leading to uncertainties in clinical decision making with huge impact on patients’ outcomes. Hence, there is an unmet need for novel biomarkers for more accurate diagnosis, risk assessment, and clinical outcome prediction for both acute and chronic cardiovascular diseases in the elderly. The BestAgeing consortium aims to improve this lack of diagnostic capabilities by developing and validating innovative omics-based biomarkers particularly for elderly patients – supporting healthy ageing in Europe. Our study design addresses the most frequent and severe cardiovascular diseases of elderly patients by incorporating the appropriate disease cohorts and biomaterials from European populations. We aim to develop new omics-assays to diagnose cardiovascular disease, estimate risk, and monitor the response to treatment in elderly. This is envisaged to enable a more stratified and economic delivery of medicine. We expect that BestAgeing will generate novel European medical technologies that can improve the efficacy and efficiency of our care for elderly patients, which will also impact on socioeconomic wealth in Europe.

partner no and role		partner name	country	contact person	web page
1	coordinator	UNIVERSITAETSKLINIKUM HEIDELBERG	DE	Hugo A. Katus	http://www.klinikum.uni-heidelberg.de
2	partner	FEBIT BIOMED GMBH	DE	Markus Beier	http://www.febit.de
3	partner	UNIVERSITAET DES SAARLANDES	DE	Andreas Keller	http://www.uni-saarland.de
4	partner	Tartu Ülikool	EE	Andres Metspalu	http://www.ut.ee
5	partner	UNIVERSITA DEGLI STUDI DI PADOVA	IT	Mario Plebani	http://www.unipd.it
6	partner	metanomics GmbH	DE	Jens Fuhrmann	http://www.metanomics.de
7	partner	UPPSALA UNIVERSITET	SE	Bertil Lindahl	http://www.uu.se
8	partner	JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN	DE	Stefanie Dimmeler	http://www.uni-frankfurt.de
9	partner	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)	FR	SYLVIANE INOCENCIO	http://www.inserm.fr
10	partner	Academisch Medisch Centrum bij de Universiteit van Amsterdam	NL	Yigal Martin Pinto	http://www.amc.nl
11	partner	ACS BIOMARKER BV	NL	Heico Breek	http://www.acsbiomarker.com
12	partner	Health in Code SL	ES	Lorenzo Monserrat Iglesias	http://www.healthincode.com
13	partner	SIEMENS AG	DE	Emil Wirsz	http://www.siemens.com
14	partner	UNIVERSITA CATTOLICA DEL SACRO CUORE	IT	Luigi Marzio Biasucci	http://www.unicattolica.it
15	partner	SERVICIO MADRILENO DE SALUD	ES	Francisco Fernandez-Aviles	http://cort.as/10Yf
16	partner	Multiplicom NV	BE	Jurgen Del-Favero	http://www.multiplicom.com
17	partner	National Scientific Center "Institute of Cardiology"	UA	Alexander Parkhomenko
18	partner	NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS	EL	GERASIMOS FILIPPATOS	http://www.elke.uoa.gr
19	partner	A.C.O. San Filippo Neri	IT	Massimo Santini